Cytek Biosciences to Participate in Upcoming Evercore and Piper Sandler Healthcare Conferences
Alpha Vantage · Quiver Quantitative · · AI-summarised by FinFlash
Cytek Biosciences, Inc. (Nasdaq: CTKB) announced its participation in the Evercore 9th Annual Healthcare Conference on December 1, 2026, and the Piper Sandler 38th Annual Healthcare Conference on December 2, 2026. CEO Wenbin Jiang and CFO William McCombe will engage in investor meetings and a fireside chat, with a webcast available for the Piper Sandler event.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.